These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 34094925)

  • 1. Bioinformatics Analysis of a Prognostic miRNA Signature and Potential Key Genes in Pancreatic Cancer.
    Chen S; Gao C; Yu T; Qu Y; Xiao GG; Huang Z
    Front Oncol; 2021; 11():641289. PubMed ID: 34094925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying
    Ding J; Liu Y; Lai Y
    PeerJ; 2020; 8():e10419. PubMed ID: 33282565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Prognostic miRNA Signature and Lymph Node Metastasis-Related Key Genes in Cervical Cancer.
    Chen S; Gao C; Wu Y; Huang Z
    Front Pharmacol; 2020; 11():544. PubMed ID: 32457603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioinformatics Analysis of Prognostic miRNA Signature and Potential Critical Genes in Colon Cancer.
    Chen W; Gao C; Liu Y; Wen Y; Hong X; Huang Z
    Front Genet; 2020; 11():478. PubMed ID: 32582275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Differentially Expressed Genes and miRNAs Associated with Esophageal Squamous Cell Carcinoma by Integrated Analysis of Microarray Data.
    Zhang L; Chen J; Cheng T; Yang H; Pan C; Li H
    Biomed Res Int; 2020; 2020():1980921. PubMed ID: 32714975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated analysis of mRNA-single nucleotide polymorphism-microRNA interaction network to identify biomarkers associated with prostate cancer.
    Wang Z; Zhu X; Zhai H; Wang Y; Hao G
    Front Genet; 2022; 13():922712. PubMed ID: 35957689
    [No Abstract]   [Full Text] [Related]  

  • 7. A Five-microRNA Signature as Prognostic Biomarker in Colorectal Cancer by Bioinformatics Analysis.
    Yang G; Zhang Y; Yang J
    Front Oncol; 2019; 9():1207. PubMed ID: 31799184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of differentially expressed miRNAs derived from serum exosomes associated with gastric cancer by microarray analysis.
    Ren ZJ; Zhao Y; Wang G; Miao LL; Zhang ZC; Ma L; Teng MZ; Li YM
    Clin Chim Acta; 2022 Jun; 531():25-35. PubMed ID: 35300960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of hub genes with prognostic values in gastric cancer by bioinformatics analysis.
    Li T; Gao X; Han L; Yu J; Li H
    World J Surg Oncol; 2018 Jun; 16(1):114. PubMed ID: 29921304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of key miRNAs and their targets in peripheral blood mononuclear cells of IgA nephropathy using bioinformatics analysis.
    Liu L; Yang Y; Yu D
    Medicine (Baltimore); 2021 Jul; 100(26):e26495. PubMed ID: 34190177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioinformatics Analysis Identifies the Estrogen Receptor 1 (ESR1) Gene and hsa-miR-26a-5p as Potential Prognostic Biomarkers in Patients with Intrahepatic Cholangiocarcinoma.
    Qin X; Song Y
    Med Sci Monit; 2020 May; 26():e921815. PubMed ID: 32435051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated Microarray to Identify the Hub miRNAs and Constructed miRNA-mRNA Network in Neuroblastoma Via Bioinformatics Analysis.
    Chen B; Hua Z; Qin X; Li Z
    Neurochem Res; 2021 Feb; 46(2):197-212. PubMed ID: 33104965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of lncRNA/circRNA-miRNA-mRNA ceRNA Network as Biomarkers for Hepatocellular Carcinoma.
    Chen S; Zhang Y; Ding X; Li W
    Front Genet; 2022; 13():838869. PubMed ID: 35386284
    [No Abstract]   [Full Text] [Related]  

  • 14. Bioinformatics analysis of mRNA and miRNA microarray to identify the key miRNA-mRNA pairs in cisplatin-resistant ovarian cancer.
    Xue B; Li S; Jin X; Liu L
    BMC Cancer; 2021 Apr; 21(1):452. PubMed ID: 33892654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying hub genes and miRNAs in Crohn's disease by bioinformatics analysis.
    Sun Y; Cai D; Hu W; Fang T
    Front Genet; 2022; 13():950136. PubMed ID: 36118873
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification of key differentially expressed mRNAs and microRNAs in non-small cell lung cancer using bioinformatics analysis.
    Wang W; Wang S; Pan L
    Exp Ther Med; 2020 Oct; 20(4):3720-3732. PubMed ID: 32855723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of differentially expressed metastatic genes and their signatures to predict the overall survival of uveal melanoma patients by bioinformatics analysis.
    Zhao DD; Zhao X; Li WT
    Int J Ophthalmol; 2020; 13(7):1046-1053. PubMed ID: 32685390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using biological information to analyze potential miRNA-mRNA regulatory networks in the plasma of patients with non-small cell lung cancer.
    Zhang W; Zhang Q; Che L; Xie Z; Cai X; Gong L; Li Z; Liu D; Liu S
    BMC Cancer; 2022 Mar; 22(1):299. PubMed ID: 35313857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Prostate Cancer-Related Circular RNA Through Bioinformatics Analysis.
    Wu YP; Lin XD; Chen SH; Ke ZB; Lin F; Chen DN; Xue XY; Wei Y; Zheng QS; Wen YA; Xu N
    Front Genet; 2020; 11():892. PubMed ID: 32922436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of hub genes and potential molecular mechanisms in gastric cancer by integrated bioinformatics analysis.
    Cao L; Chen Y; Zhang M; Xu DQ; Liu Y; Liu T; Liu SX; Wang P
    PeerJ; 2018; 6():e5180. PubMed ID: 30002985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.